Cost analysis of diltiazem and nitroglycerin for the prevention of coronary bypass conduit spasm.
Reddy
P
P
White
C M
CM
Song
J
J
D001026:Coronary Artery Bypass / Q000009:adverse effects*; D003365:Costs and Cost Analysis; D004110:Diltiazem / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D005996:Nitroglycerin / Q000191:economics* / Q000627:therapeutic use; D013035:Spasm / Q000209:etiology / Q000517:prevention & control*; D014665:Vasodilator Agents / Q000191:economics* / Q000627:therapeutic use
D014665:Vasodilator Agents; D004110:Diltiazem; D005996:Nitroglycerin